Sanofi Company Profile (NYSE:SNY)

Analyst Ratings

Consensus Ratings for Sanofi (NYSE:SNY) (?)
Ratings Breakdown: 3 Sell Rating(s), 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $51.50 (22.30% upside)

Analysts' Ratings History for Sanofi (NYSE:SNY)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016HSBCDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Bank of America Corp.Reiterated RatingBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016JPMorgan Chase & Co.Reiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Chardan CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Goldman Sachs Group Inc.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Sanford C. BernsteinLower Price TargetMarket-Perform$52.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2015Oddo SecuritiesDowngradeReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2015BNP ParibasDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/9/2015Bryan, Garnier & CoReiterated RatingBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2015Sarasin & PartnersUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015Deutsche Bank AGUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Leerink SwannUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/23/2015Kepler Capital MarketsDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014Jefferies GroupDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2014Credit Suisse Group AGUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Berenberg BankDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2014Main First Bank AGUpgradeOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Sanofi (NYSE:SNY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/29/2015Q315$0.88$0.89ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$0.61$0.73ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015Q4$0.89$0.79ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q2$0.79$0.72ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.84$0.81ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q4$0.88$0.93ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013$1.01$0.93ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sanofi (NYSE:SNY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.65$0.72$0.69
Q2 20162$0.72$0.75$0.74
Q3 20161$0.84$0.84$0.84
Q4 20161$0.78$0.78$0.78
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Sanofi (NYSE:SNY)
Annual Dividend:$1.12
Dividend Yield:2.66%
Payout Ratio:60.54% (Based on Trailing 12 Months of Earnings)
35.11% (Based on Current Year Consensus EPS Estimate)
36.36% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:-1.60% (3 Year Average)

Dividend History for Sanofi (NYSE:SNY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
2/22/2016Annual$1.105/5/20165/9/20166/1/2016Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015special$1.623.91%5/6/20155/8/20156/2/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Sanofi (NYSE:SNY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/9/2014SanofiMajor ShareholderBuy195,000$308.27$60,112,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2014SanofiMajor ShareholderBuy153,000$311.67$47,685,510.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sanofi (NYSE:SNY)
DateHeadline
07/26/16 06:55 PMHow Will Shire’s LSD Portfolio Perform in 2016?
07/26/16 09:54 AMBIIB Continues to Lead the MS Treatment Market in the US in 2016
07/26/16 08:04 AMNewly Acquired Products Boost GlaxoSmithKline’s Earnings -
07/25/16 06:40 PMBiogen Misses EndPoints in Synergy Trial for Opicinumab
07/25/16 06:40 PMSanofi Ireland plant adding 40 jobs in remake
07/25/16 10:04 AMHow Do the Majority of Analysts Rate Novartis after 2Q16? -
07/23/16 10:17 AMMannKind - Afrezza Sales Pacing Below My Bearish Line - Reality May Sting
07/23/16 10:17 AMPharma Industry Outlook: Fundamentals Remain Strong
07/22/16 06:18 PMAnalysts Watching Stocks Update: Galena Biopharma, Inc. (NASDAQ:GALE) , Sanofi (NYSE:SNY) - Street Updates
07/22/16 06:18 PMRecommendation Trends to See: Sanofi (NYSE:SNY) - News Oracle
07/22/16 09:26 AMSix Major Biotech Acquisitions You Could See In 2016 (Part 1)
07/22/16 09:26 AMWhat Do the Recent Changes in Novartis’s 2Q16 Valuation Tell Us?
07/22/16 09:26 AMRelypsa finally finds a buyer as Veltassa partner Galenica coughs up $1.5B
07/21/16 06:51 PMToday's Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare - The Daily Leicester
07/21/16 09:20 AMHigh Expectations Remain For Sanofi (NYSE:SNY) - TGP
07/20/16 07:27 PMAnalysts Holding Strong to their Buy Rating on: Sanofi (NYSE:SNY) - TGP
07/20/16 07:27 PMAnalysts Ranking Activities: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Sanofi (NYSE:SNY) - Street Updates
07/20/16 07:27 PMSell-side Value Play with Decent Upside: Sanofi (NYSE:SNY) - TGP
07/20/16 07:27 PMHC Stocks Zone: Medtronic PLC (NYSE:MDT), Sanofi SA (ADR) (NYSE:SNY) - share market updates (press release)
07/20/16 09:25 AMInside Lilly’s 2Q16 Estimates for Its Endocrine Franchise
07/20/16 09:25 AMIonis outlicenses antisense GI drug to Janssen as the pharma posts Q2
07/19/16 06:41 PMHow has Sanofi:(NYSE:SNY) performed recently? - The Daily Leicester
07/19/16 06:41 PMShares of Sanofi (SNY) Sees Large Inflow of Net Money Flow - TheFounders Daily
07/19/16 07:17 AMAnalysts Pounding the Table on Shares of Sanofi (NYSE:SNY) - TGP
07/19/16 07:17 AMSanofi (NYSE:SNY) – Top Stock from Healthcare Sector - The Daily Leicester
07/18/16 11:19 AMShares of Sanofi (SNY) Rally 2.03% - TheFounders Daily
07/18/16 11:19 AMAnalysts Rating Overview: AbbVie Inc. (NYSE:ABBV) , Sanofi (NYSE:SNY) - Street Updates
07/17/16 10:33 AMPatientsLikeMe lures Hall from FDA to expand use of real-world evidence
07/15/16 05:28 PMStruggling Ardelyx to raise $110M privately; kicks on with troubled tenapanor
07/14/16 06:46 PMSanofi : (SNY) Partners Successfully with UMass Boston in Undergraduate STEM Program
07/14/16 03:11 PMThe UN's War On Medical Innovations -
07/14/16 10:05 AMALNY Reports Positive Results from Open Label Extension Study of Revusiran -
07/13/16 09:22 AMUpdate on Sanofi (NYSE:SNY) for the day - Twin County News
07/13/16 09:22 AMUnusual Healthcare Mover Need to Be Considers- Sanofi (NYSE:SNY), TearLab (NASDAQ:TEAR) - Seneca Globe
07/13/16 09:22 AMAnalyst Buzz: Sanofi (NYSE:SNY) - News Oracle
07/12/16 06:43 PMThemis Biosciences nabs Institut Pasteur license for Zika vax; clinical trials planned
07/12/16 06:43 PMSmall cap MyoKardia up by more than a third on early cardiomyopathy data
07/12/16 10:52 AMIs Sanofi(NYSE: SNY), a large market cap stock a smart buy? - The Daily Leicester
07/11/16 06:26 PMAmgen picks up an edge for Repatha in duel with Sanofi and Regeneron
07/11/16 11:05 AMAcquiring Medivation: Separating The Contenders From The Pretenders
07/10/16 05:43 PMA look at a High Market Cap Stock: Sanofi, SNY - The Daily Leicester
07/09/16 09:33 AMSio Capital Management LLC Decreased Stake in Sanofi (NYSE:SNY) by $6.29 Million as Shares Declined - Press Telegraph
07/09/16 09:33 AMSanofi (SNY) : Analyst Rating Update - Trade Calls
07/09/16 09:33 AMSanofi Pasteur (SNY) Partners With Walter Reed Army Institute to Create Zika Vaccine - TheStreet.com
07/08/16 06:28 PMSanofi enlists for top Army hospital’s fight against Zika virus
07/08/16 09:21 AMBioMarin rises again on buzz of a potential takeover--this time from Roche
07/07/16 06:33 PMSanofi And Medivation Make Peace, But There's No Deal Yet
07/07/16 09:16 AMSanofi Starts Olipudase Alfa Study, Praluent Ok'd in Japan
07/07/16 08:40 AMStocks Open Higher; WhiteWave Soars On Danone Deal -
07/06/16 06:54 PMSanofi Genzyme commences Phase 2/3 study of olipudase alfa in rare enzyme deficiency

Social

About Sanofi

Sanofi logoSanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Company's principal activities. Under the Company's Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: SNY
  • CUSIP:
Key Metrics:
  • Previous Close: $42.11
  • 50 Day Moving Average: $40.73
  • 200 Day Moving Average: $40.70
  • P/E Ratio: 23.13
  • P/E Growth: 1.88
  • Market Cap: $108.85B
  • Beta: 1
  • Current Year EPS Consensus Estimate: $3.19 EPS
  • Next Year EPS Consensus Estimate: $3.08 EPS
Additional Links:
Sanofi (NYSE:SNY) Chart for Wednesday, July, 27, 2016